Telomere Therapeutics
PrivateLast Round
Accelerator
Dec 13, 2023
Total Funding Raised
$2.32M
Company Overview
Telomere Therapeutics is a gene therapy company developing disease modifying treatments for unmet medical needs, pioneering the repair of telomeres to treat organ fibrosis and other telomere-dysfunction syndromes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Telomere Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Telomere Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 13, 2023 | ||||
| Grant | Jan 1, 2022 | ||||
| Seed | May 25, 2021 |
Telomere Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arquimedes Accelerator | Accelerator |
| CDTI Innvierte Program | Seed |
| Community of Madrid | Grant |
| Fondo Europeo de Desarrollo Regional | Grant |
| Center for Technological Development and Innovation | Grant |
| NextGenerationEU | Grant |
| Invivo Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 22,253% MoM, from 17 to 3.8K.
- Oct 30, 2024
Monthly visitors grew 529% MoM, from 286 to 1.8K.
Telomere Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Telomere Therapeutics's valuation, stock price, and market status.
